POSTINFECTIOUS IRRITABLE BOWEL SYNDROME


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Article presents an overview of the current state of the data problems postinfectiousirritable bowel syndrome (PI-IBS) and own results of observation of 30 patients with PI-IBS. The study demonstrated the efficacy of a combined preparation of butyric acid and inulinin the complex therapy of PI-IBS.

Full Text

Restricted Access

About the authors

Yu. USPENSKAYA

I.M. Sechenov First Moscow Medical University

Email: jusp@mail.ru
Candidate of Medical Sciences

References

  1. Захаренко С.М. Невсасывающиеся антибиотики в терапии острых кишечных инфекций // Рус. мед. журн. (Болезни органов пищеварения). -2009; 11 (1): 28-32.
  2. Ручкина И.Н., Фадеева Н.А., Парфенов А.И. и др. Роль микрофлоры тонкой кишки в развитии вторичной лактазной недостаточности и возможности ее лечения пробиотиками // Тер. архив. - 2013; 85 (2): 21-6.
  3. Alajbegovic S., Sanders J., Atherly D. et al. Effectiveness of rifaximin and fluoroquinolones in preventing travelers’ diarrhea (TD): a systematic review and meta-analysis // Syst. Rev. - 2012; 1: 39.
  4. Atkinson W., Lockhart S., Whorwell P. et al. Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome // Gastroenterology. - 2006; 130 (1): 34-43.
  5. Barrett J., Gibson P. Fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) and nonallergic food intolerance: FODMAPs or food chemicals? // Ther. Adv. Gastroenterol. - 2012; 5: 261-8.
  6. Bocker U. et al. Responsiveness of intestinal epithelial cell lines to lipopolysaccharide is correlated with Toll-like receptor 4 but not Toll-like receptor 2 or CD14 expression // Int. J. Colorectal. Dis. - 2003; 18: 25-32
  7. Brenner D., Moeller M., Chey W. et al. The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review // Am. J. Gastroenterol. - 2009; 104: 1033-49
  8. Canani R. et al. Butyrate as an effective treatment of congenital chloride diarrhea // Gastroenterology. - 2004; 127: 630-4.
  9. Cavaglieri C. et al. Differential effects of short-chain fatty acids on proliferation and production of pro- and anri-irnflammatorycytochines by cultured lymphocytes // Life Sci. - 2003; 15: 1683-90.
  10. Chaudhary N., Truelove S. The irritable colon syndrome. A study of the clinical features, predisposing causes, and prognosis in 130 cases // Q. J. Med. -1962; 31: 307-22.
  11. Douglas K. Rex. Add Parasites to the Causes of Postinfectious Irritable Bowel Syndrome // Gut. - 2012; 61 (2): 214.
  12. Dunlop S., Coleman N., Blackshaw E. et al. Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome // Clin. Gastroenterol. Hepatol. - 2005; 3 (4): 349-57.
  13. Dunlop S., Jenkins D., Neal K. et al. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS // Gastroenterology. -2003; 125 (6): 1651-9.
  14. Elsenbruch S. Abdominal pain in irritable bowel syndrome: a review of putative psychological, neural and neuro-immune mechanisms // Brain Behav. Immun. - 2011; 25: 86-94.
  15. Fernandez-Banares F., Esteve M., Viver J. Fructose-sorbitol malabsorption // Curr. Gastroenterol. Rep. - 2009; 11 (5): 368-74.
  16. Gonsalkorale W., Perrey C., Pravica V. et al. Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component? // Gut. - 2003; 52 (1): 91-3.
  17. Gwee K., Graham J., McKendrick M. et al. Psychometric scores and persistence of irritable bowel after infectious diarrhea // Lancet. - 1996; 347 (8995): 150-3.
  18. Gwee K., Leong Y., Graham C. et al. The role of psychological and biological factors in postinfective gut dysfunction // Gut. - 1999; 44 (3): 400-6.
  19. Halpern G., Prindiville T., Blankenburg M. et al. Treatment of irritable bowel syndrome with Lacteol Fort: a randomized, double-blind, cross-over trial // Am. J. Gastroenterol. - 1996; 91: 1579-85.
  20. Jalanka-Tuovinen J., Salojärvi J., Salonen A. et al. Faecalmicrobiota composition and host-microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome // Gut. - 2013; doi: 10.1136/ gutjnl-2013-305994.
  21. Kanuachi O. et al. Butyrate from bacterial fermentation of germinated barley foodstuff preserves intestinal barrier function in experimental colitis in the rat model // Gastroenterol. Hepatol. - 1999; 14: 880-8.
  22. Keating C., Beyak M., Foley S. et al. Afferent hypersensitivity in a mouse model of post-inflammatory gut dysfunction: role of altered serotonin metabolism // J. Physiol. - 2008; 586: 4517-30.
  23. Langhorst J., Junge A., Rueffer A. et al. Elevated human ß-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome // Am. J. Gastroenterol. - 2009; 104: 404-10.
  24. Lee K., Kim Y., Kim J. et al. The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors // J. Gastroenterol. Hepatol. - 2008; 23: 1689-94.
  25. Marshall J., Thabane M., Garg A. et al. Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery // Gastroenterology. - 2006; 131: 445-50.
  26. McKernan D., Gaszner G., Quigley E. et al. Altered peripheral toll-like receptor responses in the irritable bowel syndrome // Aliment. Pharmacol. Ther. -2011; 33 (9): 1045-52.
  27. McKernan D., Fitzgerald P., Dinan T. et al. The probiotic Bifidobacterium infantis 35624 displays visceral antinociceptive effects in the rat // Neurogastroenterol. Motil. - 2010; 22: 1029-35.
  28. Neal K., Hebden J., Spiller R. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients // BMJ. - 1997; 314: 779-82.
  29. O’Mahony L., McCarthy J., Kelly P. et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles // Gastroenterology. - 2005; 128: 541-51.
  30. Pimentel M., Lembo A., Chey W. et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation // N. Engl. J. Med. - 2011; 364: 22-32.
  31. Rodriguez L., Ruigomez A. Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study // BMJ. - 1999; 318 (7183): 565-6.
  32. Rodriguez-Cabezas M. et al. Dietary fiber down-regulates colonic tumor necrosis factor alpha and nitric oxide production in trinitrobenzenesulfonic acid-induced colitic rats // J. Nutr. - 2002; 132: 3267-71.
  33. Spence M., Moss-Morris R. The cognitive behavioural model of irritable bowel syndrome: a prospective investigation of patients with gastroenteritis // Gut. - 2007; 56 (8): 1066-71.
  34. Spiller R., Jenkins D., Thornley J. et al. Increased rectal mucosal enteroendocrine cells, T-lymphocytes and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome // Gut. - 2000; 47: 804-11.
  35. Sykes M., Blanchard E., Lackner J. et al. Psychopathology in irritable bowel syndrome: support for a psychophysiological model // J. Behav. Med. - 2003; 26: 361-72.
  36. Thabane M., Simunovic M., Akhtar-Danesh N. et al. An outbreak of acute bacterial gastroenteritis is associated with an increased incidence of irritable bowel syndrome in children // Am. J. Gastroenterol. - 2010; 105: 933-9.
  37. Triantafillidis J., Peros G. Post-infectious Irritable bowel syndrome // Ann. Gastroenterol. - 2007; 20 (4): 243-5.
  38. Vidyasagar S. et al. Effects of butyrate on active sodium and chloride transport in rat and rabbit distal colon // J Physiol. - 2002; 539: 163-73.
  39. Wehkamp J., Fellerman K., Herrlinger K. et al. Human ß-defensin 2 but not ß-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease // Eur. J. Gastroenterol. Hepatol. - 2002; 14: 745-52.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2014 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies